{"id":45007,"date":"2022-06-13T15:02:23","date_gmt":"2022-06-13T13:02:23","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\/"},"modified":"2022-06-13T15:02:23","modified_gmt":"2022-06-13T13:02:23","slug":"artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\/","title":{"rendered":"Artiva Biotherapeutics Celebrates Official Opening of San Diego Corporate Headquarters and R&amp;D Lab Facilities"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\n<i>52,000-square-foot corporate headquarters in San Diego with R&amp;D and GMP <\/i><i>manufacturing center<\/i>\n<\/li>\n<li>\n<i>Builds on current capability at Artiva\u2019s partner, GC Cell\u2019s facility in Republic of Korea<\/i>\n<\/li>\n<li>\n<i>Custom-built GMP manufacturing center further enables Artiva\u2019s leadership position in scaled, off-the-shelf NK and CAR-NK therapeutic manufacturing for treatment of solid and hematological cancers<\/i>\n<\/li>\n<\/ul>\n<p>SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/CARNK?src=hash\" target=\"_blank\" rel=\"noopener\">#CARNK<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.artivabio.com&amp;esheet=52746530&amp;newsitemid=20220610005603&amp;lan=en-US&amp;anchor=Artiva+Biotherapeutics%2C+Inc.&amp;index=1&amp;md5=50ff40d0e08b30409f8c2c22ebcc44c4\" rel=\"nofollow noopener\" shape=\"rect\">Artiva Biotherapeutics, Inc.<\/a>, an oncology company whose mission is to deliver highly effective, off-the-shelf allogeneic, natural killer (NK) cell therapies that are safe and accessible to cancer patients, today announced the official opening of the company\u2019s U.S. corporate headquarters and R&amp;D laboratory facilities at the Alexandria Tech Center in San Diego.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220610005603\/en\/1483648\/5\/Artiva_Facilties_Exterior_Updated.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220610005603\/en\/1483648\/21\/Artiva_Facilties_Exterior_Updated.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20220610005603\/en\/801115\/5\/Artiva_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220610005603\/en\/801115\/21\/Artiva_Logo.jpg\"><\/a><\/p>\n<p>\nThe 52,000-square-foot facility will include a multi-suite, custom-built current Good Manufacturing Practices (cGMP) cell production center, to support NK and CAR-NK cell production for Artiva\u2019s pipeline development and clinical trial supply.\n<\/p>\n<p>\n\u201cWe\u2019re very pleased to welcome our team to this new facility, which was specifically designed to accommodate our growth and to support research and development for our pipeline of optimized NK and CAR-NK cell therapies for the treatment of cancer,\u201d said Fred Aslan, M.D., CEO of Artiva.\n<\/p>\n<p>\nThe new facility and capabilities will be in addition to Artiva\u2019s continued research and cGMP manufacturing at its partner GC Cell\u2019s state-of-the-art 300,000-square-foot cell center, which was completed in 2018 and comprises research labs, process development labs, and a 50,000-square-foot cGMP cell therapy manufacturing facility in the Republic of Korea. The combined R&amp;D and manufacturing capabilities of the new San Diego site coupled with GC Cell\u2019s Korean facility supports Artiva\u2019s development of the next generation off the shelf NK-cell therapies for the treatment of solid and hematological cancers.\n<\/p>\n<p>\n<b>About Artiva Biotherapeutics<\/b>\n<\/p>\n<p>\nArtiva\u2019s mission is to deliver highly effective, off-the-shelf, allogeneic natural killer (NK) cell-based therapies, utilizing our Manufacturing-First approach, that are safe and accessible to cancer patients. Artiva\u2019s pipeline includes AB-101, an ADCC enhancer NK-cell therapy candidate for use in combination with monoclonal antibodies or innate-cell engagers. Artiva is currently advancing a Phase 1\/2 clinical trial of AB-101 in combination with rituximab for the treatment of relapsed or refractory B-cell lymphomas. Artiva\u2019s pipeline also includes AB-201, an anti-HER2 CAR-NK cell therapy candidate for the treatment of HER2-overexpressing tumors, such as breast, gastric, and bladder cancers, and AB-202, a CD19-specific CAR-NK cell therapy candidate for the treatment of B-cell malignancies. Artiva has entered into therapeutic NK cell collaborations with Merck Sharp &amp; Dohme Corp. and with Affimed GmbH. <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.artivabio.com%2Fnk-cell-technology%2F&amp;esheet=52746530&amp;newsitemid=20220610005603&amp;lan=en-US&amp;anchor=Artiva%26%238217%3Bs+AlloNK%26%238482%3B+platform&amp;index=2&amp;md5=f26f32a8b00617696101c35bf9ea56f2\" rel=\"nofollow noopener\" shape=\"rect\">Artiva\u2019s AlloNK\u2122 platform<\/a> incorporates cell expansion, activation, and engineering technology developed by Artiva\u2019s strategic partner, GC Cell Corporation, a member of the GC family of companies, a leading healthcare company in Korea. Artiva is headquartered in San Diego. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.artivabio.com&amp;esheet=52746530&amp;newsitemid=20220610005603&amp;lan=en-US&amp;anchor=www.artivabio.com&amp;index=3&amp;md5=9af7cae07512852fffa4fc1a67ac877c\" rel=\"nofollow noopener\" shape=\"rect\">www.artivabio.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media:<\/b> Jessica Yingling, Ph.D., <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.litldog.com&amp;esheet=52746530&amp;newsitemid=20220610005603&amp;lan=en-US&amp;anchor=Little+Dog+Communications+Inc.&amp;index=4&amp;md5=b21d57c3770589b8e75a26f6cae87567\" rel=\"nofollow noopener\" shape=\"rect\">Little Dog Communications Inc.<\/a>, <a target=\"_blank\" href=\"mailto:jessica&#64;litldog&#46;c&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">jess&#105;&#99;&#97;&#64;&#108;&#x69;&#x74;&#x6c;&#x64;&#x6f;&#x67;&#x2e;com<\/a>, +1.858.344.8091<br \/>\n<br \/><b>Investors:<\/b> Michael E. Faerm, Artiva Biotherapeutics, Inc., <a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x69;&#x72;&#x40;&#x61;&#x72;&#x74;&#x69;&#x76;&#x61;&#x62;&#x69;&#x6f;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">ir&#64;&#97;&#114;&#x74;&#x69;&#x76;&#x61;&#x62;io&#46;&#99;&#111;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>52,000-square-foot corporate headquarters in San Diego with R&amp;D and GMP manufacturing center Builds on current capability at Artiva\u2019s partner, GC Cell\u2019s facility in Republic of Korea Custom-built GMP manufacturing center further enables Artiva\u2019s leadership position in scaled, off-the-shelf NK and CAR-NK therapeutic manufacturing for treatment of solid and hematological cancers SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;#CARNK&#8212;Artiva Biotherapeutics, Inc., &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45007","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Artiva Biotherapeutics Celebrates Official Opening of San Diego Corporate Headquarters and R&amp;D Lab Facilities - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Artiva Biotherapeutics Celebrates Official Opening of San Diego Corporate Headquarters and R&amp;D Lab Facilities - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"52,000-square-foot corporate headquarters in San Diego with R&amp;D and GMP manufacturing center Builds on current capability at Artiva\u2019s partner, GC Cell\u2019s facility in Republic of Korea Custom-built GMP manufacturing center further enables Artiva\u2019s leadership position in scaled, off-the-shelf NK and CAR-NK therapeutic manufacturing for treatment of solid and hematological cancers SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;#CARNK&#8212;Artiva Biotherapeutics, Inc., ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-13T13:02:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220610005603\/en\/1483648\/21\/Artiva_Facilties_Exterior_Updated.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Artiva Biotherapeutics Celebrates Official Opening of San Diego Corporate Headquarters and R&amp;D Lab Facilities\",\"datePublished\":\"2022-06-13T13:02:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\\\/\"},\"wordCount\":508,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220610005603\\\/en\\\/1483648\\\/21\\\/Artiva_Facilties_Exterior_Updated.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\\\/\",\"name\":\"Artiva Biotherapeutics Celebrates Official Opening of San Diego Corporate Headquarters and R&amp;D Lab Facilities - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220610005603\\\/en\\\/1483648\\\/21\\\/Artiva_Facilties_Exterior_Updated.jpg\",\"datePublished\":\"2022-06-13T13:02:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220610005603\\\/en\\\/1483648\\\/21\\\/Artiva_Facilties_Exterior_Updated.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220610005603\\\/en\\\/1483648\\\/21\\\/Artiva_Facilties_Exterior_Updated.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Artiva Biotherapeutics Celebrates Official Opening of San Diego Corporate Headquarters and R&amp;D Lab Facilities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Artiva Biotherapeutics Celebrates Official Opening of San Diego Corporate Headquarters and R&amp;D Lab Facilities - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\/","og_locale":"en_US","og_type":"article","og_title":"Artiva Biotherapeutics Celebrates Official Opening of San Diego Corporate Headquarters and R&amp;D Lab Facilities - Pharma Trend","og_description":"52,000-square-foot corporate headquarters in San Diego with R&amp;D and GMP manufacturing center Builds on current capability at Artiva\u2019s partner, GC Cell\u2019s facility in Republic of Korea Custom-built GMP manufacturing center further enables Artiva\u2019s leadership position in scaled, off-the-shelf NK and CAR-NK therapeutic manufacturing for treatment of solid and hematological cancers SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;#CARNK&#8212;Artiva Biotherapeutics, Inc., ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-13T13:02:23+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220610005603\/en\/1483648\/21\/Artiva_Facilties_Exterior_Updated.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Artiva Biotherapeutics Celebrates Official Opening of San Diego Corporate Headquarters and R&amp;D Lab Facilities","datePublished":"2022-06-13T13:02:23+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\/"},"wordCount":508,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220610005603\/en\/1483648\/21\/Artiva_Facilties_Exterior_Updated.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\/","url":"https:\/\/pharma-trend.com\/en\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\/","name":"Artiva Biotherapeutics Celebrates Official Opening of San Diego Corporate Headquarters and R&amp;D Lab Facilities - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220610005603\/en\/1483648\/21\/Artiva_Facilties_Exterior_Updated.jpg","datePublished":"2022-06-13T13:02:23+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220610005603\/en\/1483648\/21\/Artiva_Facilties_Exterior_Updated.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220610005603\/en\/1483648\/21\/Artiva_Facilties_Exterior_Updated.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/artiva-biotherapeutics-celebrates-official-opening-of-san-diego-corporate-headquarters-and-rd-lab-facilities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Artiva Biotherapeutics Celebrates Official Opening of San Diego Corporate Headquarters and R&amp;D Lab Facilities"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45007","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45007"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45007\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45007"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45007"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}